Unum Therapeutics Inc., of Cambridge, Mass., signed a common stock purchase agreement for up to $25 million with Lincoln Park Capital Fund LLC, a Chicago-based institutional investor. Under the terms, Unum will have the sole discretion, but not the obligation, to direct Lincoln Park to purchase up to $25 million in shares of its common stock over the 36-month term of the agreement. The price of Unum’s shares of common stock sold will be based on the market prices prevailing at the time of each sale. Unum intends to use the net proceeds for working capital and general corporate purposes.

No Comments